This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nankivell BJ and Chapman JR (2006) The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 6: 2006–2012
Rush D et al. (1998) Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 9: 2129–2134
Gloor JM et al. (2002) Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation 73: 1965–1968
Kurtkoti J et al.: The utility of 1 and 3 month protocol biopsies on renal allograft function: a randomized controlled study. Am J Transplant, in press
Nankivell BJ et al. (2003) The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326–2333
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Nankivell, B. Subclinical renal allograft rejection and protocol biopsies: quo vadis?. Nat Rev Nephrol 4, 134–135 (2008). https://doi.org/10.1038/ncpneph0701
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0701